BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38593384)

  • 1. H10: Long-Term Results Could Be Misleading Without an Updated Reading Key for Positron Emission Tomography.
    Vassilakopoulos TP; Liaskas A; Pereyra P; Gallamini A
    J Clin Oncol; 2024 Jun; 42(18):2236-2237. PubMed ID: 38593384
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluorodeoxyglucose F18 positron emission tomography in a case of slowly progressive pure alexia.
    Graff-Radford J; Benarroch EE; Duffy JR; Drubach DA
    Neurocase; 2014 Aug; 20(4):476-9. PubMed ID: 23998338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a role for fluorine-18 fluorodeoxyglucose positron emission tomography imaging in medullary thyroid cancer?
    Kauhanen S; Schalin-Jäntti C
    Endocrine; 2012 Dec; 42(3):461-3. PubMed ID: 22798248
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules.
    Sebastianes FM; Pereira MA; Cerci JJ
    Am J Otolaryngol; 2009; 30(4):291-2; author reply 292-3. PubMed ID: 19563946
    [No Abstract]   [Full Text] [Related]  

  • 5. Value of fluorodeoxyglucose positron emission tomography in women with breast cancer (Br J Surg 2005; 92: 1363-1367).
    Hayanga AJ
    Br J Surg; 2006 Feb; 93(2):252; author reply 252-3. PubMed ID: 16432827
    [No Abstract]   [Full Text] [Related]  

  • 6. (18)F-fluorodeoxyglucose positron emission tomography in the diagnosis and followup of idiopathic retroperitoneal fibrosis.
    Vaglio A; Versari A; Fraternali A; Ferrozzi F; Salvarani C; Buzio C
    Arthritis Rheum; 2005 Feb; 53(1):122-5. PubMed ID: 15696564
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe myocardial ischemia detected in routine oncological positron emission tomography/computed tomography with 18F-fluorodeoxyglucose.
    Freitag MT; Haaf P; Zellweger MJ
    Eur Heart J; 2023 Jul; 44(26):2412. PubMed ID: 37029729
    [No Abstract]   [Full Text] [Related]  

  • 8. The evolving role of fluorodeoxyglucose positron emission tomography (FDG PET) in lymphoma: how do we reconcile conflicting results in the era of evidence-based medicine?
    Hicks RJ
    Leuk Lymphoma; 2006 Oct; 47(10):2008-10. PubMed ID: 17071468
    [No Abstract]   [Full Text] [Related]  

  • 9. Overview of positron emission tomography, hybrid positron emission tomography instrumentation, and positron emission tomography quantification.
    Kwee TC; Torigian DA; Alavi A
    J Thorac Imaging; 2013 Jan; 28(1):4-10. PubMed ID: 23249967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography scanning in oesophageal cancer - stuck at the first hurdle?
    Falk S
    Clin Oncol (R Coll Radiol); 2012 Mar; 24(2):83-5. PubMed ID: 21865019
    [No Abstract]   [Full Text] [Related]  

  • 11. [Application of fluorine-18 fluorodeoxyglucose-positron emission tomography in the diagnosis and therapy of patients with sarcoidosis].
    Li D; Lü PX
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jun; 36(6):447-50. PubMed ID: 24103209
    [No Abstract]   [Full Text] [Related]  

  • 12. Inflammatory pseudotumour of the spleen: the findings on F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT).
    Ryu JS; Um JW; Min BW
    ANZ J Surg; 2010 Sep; 80(9):650-2. PubMed ID: 20857613
    [No Abstract]   [Full Text] [Related]  

  • 13. Positron emission tomography (PET): a new tool in the diagnosis of endocarditis.
    Millar BC; Prendergast BD; Alavi A; Moore JE
    Heart; 2009 Feb; 95(4):332-3. PubMed ID: 19176566
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in rheumatoid arthritis patients tapering tumour necrosis factor inhibitor.
    Rosato E
    Rheumatology (Oxford); 2022 Apr; 61(SI):SI1-SI3. PubMed ID: 34919664
    [No Abstract]   [Full Text] [Related]  

  • 15. Usefulness of positron emission tomography with
    Cabrera Villegas A; Rosel Rioja LF; Ramírez Lasanta R
    Med Clin (Barc); 2017 Feb; 148(3):140-141. PubMed ID: 27993412
    [No Abstract]   [Full Text] [Related]  

  • 16. [Positron emission tomography using FDG].
    Morel O
    Rev Infirm; 2006 Oct; (124):41. PubMed ID: 17396616
    [No Abstract]   [Full Text] [Related]  

  • 17. Reply to "Prognostic Value of Fluorodeoxyglucose-Positron Emission Tomography".
    Kwon W; Howard BA; Herndon JE; Patz EF
    J Thorac Oncol; 2015 Oct; 10(10):e102. PubMed ID: 26398827
    [No Abstract]   [Full Text] [Related]  

  • 18. Government funding of fluorodeoxyglucose positron emission tomography (FDG-PET) in rare urological cancers: better data, better outcomes.
    Xu J; Al Saffar H; O'Brien J; Kelly B; Lawrentschuk N
    BJU Int; 2024 Feb; 133 Suppl 3():8-9. PubMed ID: 37467147
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of positron-emission tomography with F18-fluorodeoxyglucose for the assessment of lung lesions suspicious of malignancy].
    Jofré MJ; Massardo T; González P; Canessa J; Sierralta P; Humeres P; Galaz R; Valdebenito R
    Rev Med Chil; 2005 May; 133(5):583-92. PubMed ID: 15970984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of incidental thyroid nodules on 18F-fluorodeoxyglucose positron emission tomography imaging: are these significant?
    Sharma SD; Jacques T; Smith S; Watters G
    J Laryngol Otol; 2015 Jan; 129(1):53-6. PubMed ID: 25496842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.